Zoloft and the risk of anencephaly
Posted on Tuesday, December 17th, 2013 at 1:50 pm
Zoloft belongs to a class of drugs called selective serotonin reuptake inhibitors (SSRI) and is designed to treat symptoms of major depressive illnesses, such as manic depression and bipolar disorder.
However, a study published in the New England Journal of Medicine on June 28, 2007 revealed that maternal use of Zoloft was associated with different neural tube defects (NTD), including anencephaly, a deadly birth defect that affects one out of more than 4,000 babies every year.
Babies born with anencephaly have no cerebrum and cerebellum because a portion of their neural tube failed to develop. Experts believe Zoloft increases the risk of this congenital defect by interfering with the synthesis of folic acid, which is known to decrease the risk of NTDs including anencephaly.
If you believe taking Zoloft while pregnant has caused your baby to suffer a birth defect, such as anencephaly, speak with one of our defective pharmaceuticals lawyers from Williams Kherkher about your options for taking legal action against the maker of this drug. Call us at (888) 220-0640 today.